These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 652142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists.
    Colpaert FC, Niemegeers CJ, Janssen PA.
    Eur J Pharmacol; 1979 Oct 15; 58(4):505-9. PubMed ID: 510385
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L, Vijayan E, Coppings RJ, Giachetti A, McCann SM, Mayfield MA.
    Endocrinology; 1979 Jul 15; 105(1):276-83. PubMed ID: 446410
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide.
    Bivens CH, Lebovitz HE, Feldman JM.
    N Engl J Med; 1973 Aug 02; 289(5):236-9. PubMed ID: 4713762
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM, Hosko MJ.
    Exp Neurol; 1983 Nov 02; 82(2):391-403. PubMed ID: 6628626
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Behavioral syndrome induced by allylnitrile, crotononitrile or 2-pentenenitrile in rats.
    Tanii H, Hayashi M, Hashimoto K.
    Neuropharmacology; 1991 Aug 02; 30(8):887-92. PubMed ID: 1723510
    [Abstract] [Full Text] [Related]

  • 18. The effects of cyproheptadine, methysergide, BC 105 and reserpine on brain 5-hydroxytryptamine and brain growth.
    Hole K.
    Eur J Pharmacol; 1972 Aug 02; 19(2):156-9. PubMed ID: 5071787
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Action of UML on levels of 5HT and 5HIAA in the rat brain with MAO blocking].
    Torre M, Torre E, Bogetto F.
    Boll Soc Ital Biol Sper; 1976 Nov 30; 52(22):1876-9. PubMed ID: 1027452
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.